LAMEDITECH Co., Ltd. (462510.KQ)
7920.0
(-0.5%)
7920.0
(-0.5%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 2.91 Billion | 2.05 Billion | 1.02 Billion |
| Cost of Revenue | 2.01 Billion | 1.77 Billion | 661.8 Million |
| Gross Profit | 899.42 Million | 284.8 Million | 366.85 Million |
| Operating Expenses | 4.42 Billion | 3.62 Billion | 2.24 Billion |
| Selling, General and Administrative Expenses | 2.02 Billion | 1.26 Billion | 1.56 Billion |
| Research and Development Expenses | 765.29 Million | 1.26 Billion | 680.27 Million |
| Other Expenses | 1.63 Billion | 21.56 Million | - |
| Cost and Expenses | 6.44 Billion | 5.39 Billion | 2.9 Billion |
| Operating Income | -3.52 Billion | -3.34 Billion | -1.88 Billion |
| Interest Expense | 976.98 Million | 1 Billion | 61.63 Million |
| Income Tax Expense | - | 29.97 Million | - |
| Earnings before Tax | -8.3 Billion | -4.43 Billion | -1.86 Billion |
| Net Income | -8.3 Billion | -4.43 Billion | -1.86 Billion |
| Earnings Per Share Basic | -1525.00 | -889.00 | -215.82 |
| Earnings Per Share Diluted | -1525.00 | -889.00 | -215.82 |
| Weighted Average Shares Outstanding | 5.44 Million | 4.98 Million | 8.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.44 Million | 4.98 Million | 8.65 Million |
| Gross Margin | 0.31 | 0.14 | 0.36 |
| EBIT Margin | -2.41 | -1.50 | -1.83 |
| Profit Margin | -2.85 | -2.15 | -1.81 |
| EBITDA | -7.03 Billion | -3.18 Billion | -1.88 Billion |
| Earnings Before Tax Margin | -1.21 | -1.63 | -1.83 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 1.85 Billion | 979.07 Million | 2.91 Billion | 1.12 Billion | 427.94 Million | 2.05 Billion |
| Cost of Revenue | 1.09 Billion | 641.31 Million | 2.01 Billion | 602.42 Million | 303.01 Million | 1.77 Billion |
| Gross Profit | 763.18 Million | 337.76 Million | 899.42 Million | 519.44 Million | 124.92 Million | 284.8 Million |
| Operating Expenses | 3.53 Billion | 2.05 Billion | 4.42 Billion | 1.11 Billion | 797.22 Million | 3.62 Billion |
| Selling, General and Administrative Expenses | 2.58 Billion | 1.14 Billion | - | 481.96 Million | 431.46 Million | - |
| Research and Development Expenses | 322.18 Million | 330.3 Million | - | 214.63 Million | 69.5 Million | - |
| Other Expenses | 25.72 Million | 65.13 Million | 2.23 Million | 42.75 Million | 218 Thousand | 21.56 Million |
| Cost and Expenses | 4.62 Billion | 2.69 Billion | 6.44 Billion | 1.71 Billion | 1.1 Billion | 5.39 Billion |
| Operating Income | -2.77 Billion | -1.71 Billion | -3.52 Billion | -593.8 Million | -672.29 Million | -3.34 Billion |
| Interest Expense | 16.62 Million | 19.7 Million | 976.98 Million | 307.04 Million | 277.03 Million | 1 Billion |
| Income Tax Expense | 37.43 Million | 108.51 Million | 102.75 Million | 70.72 Million | 31.82 Million | 29.97 Million |
| Earnings before Tax | -2.75 Billion | -1.62 Billion | -8.3 Billion | -740.95 Million | -920.5 Million | -4.43 Billion |
| Net Income | -2.75 Billion | -1.62 Billion | -8.3 Billion | -740.95 Million | -920.5 Million | -4.43 Billion |
| Earnings Per Share Basic | -376.00 | -223.00 | - | -149.00 | -157.00 | - |
| Earnings Per Share Diluted | -376.00 | -223.00 | - | -149.00 | -157.00 | - |
| Weighted Average Shares Outstanding | 7.31 Million | 7.29 Million | 5.44 Million | 4.97 Million | 5.86 Million | 4.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.31 Million | 7.29 Million | 5.44 Million | 4.97 Million | 5.86 Million | 4.98 Million |
| Gross Margin | 0.41 | 0.34 | 0.31 | 0.46 | 0.29 | 0.14 |
| EBIT Margin | -1.41 | -1.54 | - | -0.40 | -1.34 | - |
| Profit Margin | -1.48 | -1.66 | -2.85 | -0.66 | -2.15 | -2.15 |
| EBITDA | -2.62 Billion | -1.5 Billion | - | -451.79 Million | -571.91 Million | - |
| Earnings Before Tax Margin | -1.49 | -1.75 | -1.21 | -0.53 | -1.57 | -1.63 |
TNDO
AKZOINDIA
NYCB
688519
000990
0LHR